Table 4.
Multiple regression analyses of association between interhospital transfer and ED length of stay or in-hospital outcomes in various subgroups.
| ED LOS |
Hospital LOS |
In-hospital death |
|
|---|---|---|---|
| Adjusted β (95% CI) | Adjusted β (95% CI) | Adjusted OR (95% CI) | |
| Five-level Taiwan triage and acuity scale | |||
| 1 and 2 (n = 7341) | −312.23 (−465.22, −159.25) | 0.72 (−0.02, 1.47) | 1.13 (0.91, 1.41) |
| ≥3 (n = 10810) | −224.36 (−377.98, −70.73) | 1.51 (0.79, 2.23) | 1.62 (1.18, 2.24) |
| Ambulance arrivals (n = 4968) | −241.7 (-376.8, −106.7) | −0.19 (−0.90, 0.52) | 0.76 (0.62, 0.93) |
| Cardiovascular disorders | |||
| Congestive heart failure (n = 1538) | −142.05 (−466.35, 182.25) | 0.74 (−0.62, 2.10) | 1.21 (0.61, 2.41) |
| Myocardial infarction (n = 568) | −339.10 (−733.28, 55.07) | −0.29 (−1.82, 1.22) | 0.64 (0.25, 1.63) |
| Neurological disorders | |||
| Cerebrovascular disease (n = 1732) | −338.28 (−655.33, −21.23) | 1.15 (−0.59, 2.90) | 1.59 (0.88, 2.88) |
| Endocrine disorders | |||
| Diabetes without chronic complication (n = 2686) | −539.69 (−863.83, −215.56) | 0.78 (−0.79, 2.36) | 1.14 (0.62, 2.11) |
| Diabetes with chronic complication (n = 769) | −554.37 (−1253.54, 144.79) | 0.01 (−3.52, 3.56) | 0.70 (0.14, 3.51) |
| Hematologic and oncologic disorders | |||
| Any malignancy (n = 1630) | −55.32 (−460.11, 349.46) | 1.13 (−1.10, 3.37) | 0.76 (0.44, 1.29) |
| Renal and genitourinary disorders | |||
| Chronic kidney disease (n = 1547) | −416.62 (−823.89, −9.36) | 0.90 (−1.25, 3.05) | 0.71 (0.30, 1.64) |
| Pulmonary disorders | |||
| Chronic pulmonary disease (n = 1073) | 9.97 (−465.78, 485.73) | −0.51 (−2.79, 1.77) | 1.76 (0.72, 4.30) |
| Gastrointestinal disorders | |||
| Mild liver disease (n = 878) | −261.89 (−784.58, 260.79) | 1.45 (−1.09, 3.99) | 1.00 (0.45, 2.22) |
| Peptic ulcer disease (n = 611) | 57.44 (−414.13, 529.03) | −0.38 (−2.14, 1.37) | 0.87 (0.19, 3.89) |
LOS, length of stay; β, regression coefficient; OR, odds ratio; CI, confidence interval.
Non-IHT was used as the reference group for analyses.
Adjusted β or OR was obtained after adjustment for all potential confounders. Numbers in bold format indicate P < 0.05.